The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback